Great West Life Assurance CO Voyager Therapeutics, Inc. Transaction History

Great West Life Assurance CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$3.94 - $5.44 $5,744 - $7,931	-1,458 Closed	0 $0
Q3 2020 Nov 17, 2020	SELL	$10.01 - $13.75 $3.99 Million - $5.48 Million	-398,450 Reduced 99.64%	1,458 $15,000
Q3 2020 Nov 13, 2020	BUY	$10.01 - $13.75 $3.99 Million - $5.48 Million	398,450 Added 27328.53%	399,908 $4.27 Million
Q4 2019 Feb 11, 2020	BUY	$12.82 - $16.85 $18,691 - $24,567	1,458 New	1,458 $20,000
Q3 2019 Oct 25, 2019	SELL	$16.31 - $28.29 $44,803 - $77,712	-2,747 Closed	0 $0
Q2 2019 Jul 31, 2019	BUY	$19.18 - $27.88 $20,714 - $30,110	1,080 Added 64.79%	2,747 $0
Q4 2017 Feb 09, 2018	BUY	$12.26 - $25.88 $20,437 - $43,141	1,667	1,667 $28,000

128

36.7M

48K

36.2K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $245M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

Stay updated on Great West Life Assurance CO with notifications on news.